CymitQuimica logo

CAS 97901-21-8

:

Nafagrel

Description:
Nafagrel is a chemical compound primarily recognized for its role as a pharmacological agent, particularly in the context of cardiovascular health. It is classified as a platelet aggregation inhibitor, which means it helps prevent the clumping of platelets in the blood, thereby reducing the risk of thrombus formation. This property makes it potentially useful in the treatment of conditions such as stroke and myocardial infarction. Nafagrel operates by inhibiting the action of certain biochemical pathways involved in platelet activation. The compound is typically administered in a specific dosage form, and its efficacy and safety profile are evaluated through clinical studies. As with many pharmaceuticals, potential side effects may include bleeding complications, gastrointestinal disturbances, or allergic reactions. The compound's chemical structure and properties contribute to its biological activity, and ongoing research may further elucidate its mechanisms and therapeutic applications. As with any medication, it is essential for healthcare providers to consider individual patient factors when prescribing Nafagrel.
Formula:C15H17ClN2O2
InChI:InChI=1/C15H16N2O2.ClH/c18-15(19)14-4-3-12-7-11(1-2-13(12)8-14)9-17-6-5-16-10-17;/h3-6,8,10-11H,1-2,7,9H2,(H,18,19);1H
Synonyms:
  • Nafagrel [INN]
  • DP 1904
  • 6-(1H-imidazol-1-ylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid
  • 6-(1H-imidazol-1-ylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid hydrochloride (1:1)
  • Nafagrelum
  • UNII-98PDQ9OL4V
  • Nafagrelum [INN-Latin]
  • (+-)-5,6,7,8-Tetrahydro-6-(imidazol-1-ylmethyl)-2-naphthoic acid
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.